Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Adicionar filtros








Intervalo de ano
1.
Journal of Southern Medical University ; (12): 552-554, 2010.
Artigo em Chinês | WPRIM | ID: wpr-355073

RESUMO

<p><b>OBJECTIVE</b>To investigate the effect of recombinant human erythropoietin (rhEPO) on the expression of bcl-2 protein in the retina of rabbits with acute high intraocular pressure and explore the mechanism underlying the protective effect of rhEPO on the retina against ischemia-reperfusion injury.</p><p><b>METHODS</b>rhEPO was injected subcutaneously in the ear of a rabbit model of acute high intraocular pressure induced by physiological saline perfusion into the anterior chamber. Bcl-2 protein expression in the retina of the rabbits was observed by immunohistochemical staining on days 1, 3, 7, and 14 after retinal ischemia-reperfusion and compared with that in normal rabbits and untreated rabbit models.</p><p><b>RESULTS</b>bcl-2-positive cells were observed in the retina of normal rabbits with a mean positive cell number of 10.5-/+1.2 in each high-power visual field. Compared with that in the normal control group, the number of the positive cells decreased significantly in both the model group and EPO group (P<0.05, P<0.01), but the latter group showed a significantly greater number than the former (P<0.05 at day 7 and P<0.01 at day 14).</p><p><b>CONCLUSION</b>Systemic administration of rhEPO can up-regulate the expression of bcl-2 protein in the retina of rabbits with acute high intraocular pressure, which is probably one of the mechanisms for the protective effect of rhEPO on the retina against ischemia-reperfusion injury.</p>


Assuntos
Animais , Feminino , Humanos , Masculino , Coelhos , Eritropoetina , Farmacologia , Usos Terapêuticos , Hipertensão Ocular , Tratamento Farmacológico , Metabolismo , Proteínas Proto-Oncogênicas c-bcl-2 , Metabolismo , Distribuição Aleatória , Proteínas Recombinantes , Retina , Metabolismo
2.
Chinese Journal of Hepatology ; (12): 46-49, 2009.
Artigo em Chinês | WPRIM | ID: wpr-250060

RESUMO

<p><b>OBJECTIVE</b>To investigate the histomorphology and protein expression profiles of human fetal liver at different developmental stages.</p><p><b>METHODS</b>The protein expression patterns of human fetus livers at early and late stages were profiled by two-dimensional gel electrophoresis (2-DE) combined with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) analysis. The differentially expressed proteins were identified by searching the protein databases with Mascot or ProFound softwares.</p><p><b>RESULTS</b>The obvious differences between early and late fetus liver were not only in morphology but also in protein expression profiles. Compared with protein expression pattern of hepatocellular carcinoma, 32 differential or similar protein spots were analyzed by MALDI-TOF MS, and 26 proteins, including proteins involved in cell proliferation, apoptosis and metabolism, were identified.</p><p><b>CONCLUSION</b>The data suggest that the hepatic cancer cells regain some characteristics of fetal hepatic cells during the process of carcinogenesis.</p>


Assuntos
Feminino , Humanos , Gravidez , Carcinoma Hepatocelular , Metabolismo , Feto , Metabolismo , Fígado , Metabolismo , Neoplasias Hepáticas , Metabolismo , Proteínas , Metabolismo , Proteômica , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por Matriz
3.
Journal of Southern Medical University ; (12): 2201-2204, 2009.
Artigo em Chinês | WPRIM | ID: wpr-325147

RESUMO

<p><b>OBJECTIVE</b>To observe the changes in the expression of brain derived neurotrophic factor (BDNF) gene in the retina of rabbits with acute high intraocular pressure (IOP) after injection of recombinant adeno-associated virus (rAAV) vector containing human BDNF gene (rAAV-hBDNF), and investigate the neuroprotective mechanism of rAAV-hBDNF.</p><p><b>METHODS</b>The unilateral eyes of 24 white rabbits were randomly chosen as the model group with high IOP induced by saline perfusion into the anterior chamber, and the contralateral eyes served as the control group without treatment. In another 24 white rabbits, 10 microl rAAV-BDNF was injected into the vitreous body of one of the eyes 3 days before induction of high IOP. On days 1, 3, 7, and 14 after perfusion, the bilateral eyes of 6 rabbits were excised for immunohistochemistry for the expression of endogenous BDNF gene in the retina.</p><p><b>RESULTS</b>The number of BDNF-positive cells in the retina decreased after induction of high IOP, and injection of rAAV-hBDNF resulted in a significant increase in BDNF-positive cells as compared with the positive cell number in the high IOP model and control groups (P<0.05, P<0.01).</p><p><b>CONCLUSION</b>rAAV-mediated BDNF gene transfection can increase endogenous BDNF expression in the retina of rabbits with acute high IOP. Intravitreous injection is an effective pathway for rAAV-hBDNF gene transfection into the retina.</p>


Assuntos
Animais , Humanos , Coelhos , Fator Neurotrófico Derivado do Encéfalo , Genética , Dependovirus , Genética , Metabolismo , Vetores Genéticos , Genética , Hipertensão Ocular , Metabolismo , Proteínas Recombinantes , Genética , Retina , Metabolismo , Transfecção
4.
Journal of Southern Medical University ; (12): 1770-1774, 2009.
Artigo em Chinês | WPRIM | ID: wpr-336090

RESUMO

<p><b>OBJECTIVE</b>To investigate the neuroprotective effect of human brain-derived neurotrophic factor gene transfection into rabbit retina against acute high intraocular pressure (HIOP).</p><p><b>METHODS</b>Acute HIPO was induced in one eye of 24 white rabbits via saline perfusion into the anterior chamber (model group), and the contralateral eye without treatment served as the control group. In another 24 rabbits, 10 microl recombinant adeno-associated virus (rAAV) vector containing human BDNF gene (rAAV-BDNF) was injected into the vitreous body of one of the eyes 3 days before the operation for HIPO (BDNF group). At 1, 3, 7, and 14 days after HIOP model establishment, 6 eyes in each group were excised to observe the number of retinal ganglion cells (RGCs) and the thickness of the inner retina layer. For the eyes dissected on day 14, electroretinogram b (ERG-b) wave was detected 30 min before (baseline) and on days 1, 3, 7 and 14 after HIOP. Another 5 rabbits were used for ultrastructural observation of the RGCs using transmission electron microscopy, including 1 without treatment, 2 with unilateral HIOP and 2 with rAAV-BDNF transfection before HIOP.</p><p><b>RESULTS</b>The amplitude of ERG-b wave showed no significant difference between the 3 groups before HIOP (P>0.05). In HIOP model group and BDNF group, the amplitude decreased to the lowest at 1 day after HIOP and failed to recover the baseline level at 14 days (P<0.01); at the end of the observation, the amplitude was significantly higher in BDNF group than in the model group (P<0.01). Decreased number of RGCs and thickness of inner retina layer occurred in the model group, but these changes were milder in BDNF group (P<0.05, P<0.01). Electron microscopy revealed ultrastructural changes in the RGCs following acute HIOP, and transfection with rAAV-BDNF ameliorated these changes.</p><p><b>CONCLUSION</b>rAAV-BDNF transfection protects the retinal structure and improves the amplitude of ERG-b wave after acute high IOP suggesting its neuroprotective effects.</p>


Assuntos
Animais , Humanos , Coelhos , Fator Neurotrófico Derivado do Encéfalo , Genética , Dependovirus , Genética , Metabolismo , Terapia Genética , Métodos , Vetores Genéticos , Genética , Hipertensão Ocular , Terapêutica , Retina , Patologia , Doenças Retinianas , Transfecção
5.
Journal of Southern Medical University ; (12): 271-273, 2009.
Artigo em Chinês | WPRIM | ID: wpr-339012

RESUMO

<p><b>OBJECTIVE</b>To observe the effect of recombinant human erythropoietin (rhEPO) on the expression of hypoxia inducible factor-1alpha (HIF-1alpha) in the retina of rabbits with acute high intraocular pressure and investigate the mechanism of rhEPO in protecting the retina from ischemia-reperfusion injury.</p><p><b>METHODS</b>Acute high intraocular pressure was induced in the rabbits by perfusion of normal saline into the anterior chamber, and rhEPO was injected subcutaneously. The changes in HIF-1alpha protein expression in the retina was observed by immunohistochemistry on days 1, 3, 7, and 14 after retinal ischemia- reperfusion.</p><p><b>RESULTS</b>HIF-1alpha expression was not observed in the retina of the normal control rats, but intense HIF-1alpha expression was found in the model group (P<0.01). In rabbits with rhEPO injection and those in the model group, the patterns of HIF-1alpha expression alterations were similar, but the HIF-1alpha-positive cells in the retina were significantly fewer in rhEPO group (P<0.05).</p><p><b>CONCLUSION</b>rhEPO can down-regulate HIF-1alpha expression in the retina of rabbits with acute high intraocular pressure, which may be one of the mechanisms that rhEPO protects the retina from ischemia-reperfusion injury.</p>


Assuntos
Animais , Humanos , Coelhos , Regulação para Baixo , Eritropoetina , Farmacologia , Subunidade alfa do Fator 1 Induzível por Hipóxia , Metabolismo , Fármacos Neuroprotetores , Farmacologia , Hipertensão Ocular , Metabolismo , Proteínas Recombinantes , Traumatismo por Reperfusão , Retina , Metabolismo , Vasos Retinianos , Metabolismo
6.
Chinese Journal of Medical Genetics ; (6): 275-279, 2006.
Artigo em Chinês | WPRIM | ID: wpr-263797

RESUMO

<p><b>OBJECTIVE</b>To emphasize early differential diagnosis from patients with hyperphenylalaninemia (HPA) and to evaluate the treatment and long-term outcome of patients with tetrahydrobiopterin synthase (BH4) deficiency in Northern Chinese population.</p><p><b>METHODS</b>From 1992 to 2005, a total of 618 patients with HPA were diagnosed and/or cared for in our outpatient clinic. Urinary pterin analysis, detection of dihydropteridine reductase (DHPR) activity in blood, and then BH4 loading tests were carried out to differentiate BH4 deficiency in these patients from classical phenylketonuria. BH4 deficient patients were treated with BH4, levodopa and 5-hydroxytryptophane (5-HTP) immediately while the diagnosis was done to disease. Patientso blood phenylalanine levels, psychomotor and intelligence development were followed up.</p><p><b>RESULTS</b>A total of 38 cases were diagnosed as BH4 deficiency, all of them were revealed as 6-pyruvoyl-tetrahydropterin synthase (PTPS) deficiency from the extremely decreased urine biopterin, normal DHPR activities and drop down of blood phenylalanine level to normal range within 4 to 8 hours after BH4 loading. The most common manifestations were progressively psychomotor and mental retardation to patients even after taking early dietary treatment. The patients were diagnosed and treated with drugs at the ages of 2.1 months to 13 years. With 4 patients died of pneumonia, 7 patients refused to treatment, only 27 patients were under treatment and followed up. The average full scale development or intelligence quotient (DQ/IQ) of patients who were treated within and after 6 months were 86+/- 10 or 66+/- 7 respectively. Development was not even in different aspects. A significant negative correlation was observed between the level of the DQ and the age of treatment commenced (r was -0.714, P< 0.01). Eleven patients experienced the extrapyramidal movement disorders, 3 of them combined with epilepsy. The extrapyramidal disorders were controlled by administration of levodopa.</p><p><b>CONCLUSION</b>The differential diagnosis for BH4 deficiency should be carried out in all patients with HPA. PTPS deficiency is the most common form of BH4 deficiency in Northern Chinese population. The long-term outcome of these patients benefits from diagnosis and treatment with BH4, levodopa and 5-HTP as early as possible.</p>


Assuntos
Pré-Escolar , Humanos , Lactente , 5-Hidroxitriptofano , Usos Terapêuticos , Povo Asiático , Genética , Biopterinas , Usos Terapêuticos , China , Di-Hidropteridina Redutase , Sangue , Levodopa , Usos Terapêuticos , Fenilalanina , Sangue , Fenilcetonúrias , Tratamento Farmacológico , Genética , Metabolismo , Fósforo-Oxigênio Liases , Genética
7.
Journal of Applied Clinical Pediatrics ; (24)2004.
Artigo em Chinês | WPRIM | ID: wpr-639196

RESUMO

Objective To explore clinical characteristics of phenylalanine hydroxylase(PAH) deficiency in differential diagnosis among hyperphenylalaninemia(HPA) patients and compare the responses to diet treatment in HPA patients.Methods Tetrahydrobiopterin(BH4,20 mg/kg) loading test or combined phenylalanine(Phe,100 mg/kg) and BH4 loading test was carried out among 44 HPA patients.The urine pterine profile analysis and dihydropteridine reductase(DHPR) activity in dry blood filter spot were analyzed simultaneously.Electroencephalogram(EEG) and average full scale development quotient(DQ) were performed in all patients.PAH deficiency patients were given low Phe diet treatment to decrease Phe level for 120-360 ?mol/L and followed up their Phe tolerance.Results Twelve BH4 responsive PAH deficiency patients were diagnosed who were 7 males and 5 females,mean age was 7.8 months.Their metabolic phenotype was moderate or mild HPA.Diet control could decrease Phe level among BH4 deficiency patients but not prevent their neural damage and their EEG abnormal rate was higher.BH4 responsive patients had higher DQ than others and their Phe tolerance increased during diet treatment.Conclusions BH4 responsive PAH deficiency patients can obtain better purpose with diet recipe.The differential diagnosis for BH4 deficiency shall be carried out in all patients with HPA as soon as possible.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA